When would you consider using hypertonic saline for patients with refractory acute decompensated heart failure and diuretic resistance?

In patients with acute decompensated heart failure (ADHF) and diuretic resistance, hypertonic saline combined with furosemide has shown potential in improving clinical outcomes. This combination can decrease mortality, reduce hospital stay and readmission rates, and enhance diuretic effectiveness by increasing urine output and serum sodium levels, reducing body weight, serum creatinine, and type-B natriuretic peptide levels. Hypertonic saline therapy is also associated with improved diuretic efficiency, fluid and weight loss, and correction of metabolic derangements, without significant adverse effects.

The use of hypertonic saline in patients with refractory acute decompensated heart failure (ADHF) and diuretic resistance has been explored ...